Navigation Links
Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities
Date:9/24/2009

CAMBRIDGE, Mass., Sept. 24 /PRNewswire/ -- Peptimmune, Inc. ("Peptimmune"), a privately held biotechnology company announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC), Silver Spring, MD to evaluate the Company's proprietary DEEP(TM) peptide copolymer technology for the potential development of dengue vaccines and point-of-care diagnostics.

After more than 70 years of work a safe and effective dengue virus (DENV) vaccine remains an elusive goal. Previous vaccine candidates have shown unpredictable interactions among the four DENVs often leading to unwanted reactogenicity and low seroconversion rates. Rapid, serotype-specific diagnosis of DENV infection is an equally perplexing problem. Existing tests are often confounded after secondary dengue infection due to extensive serotype cross-reactivity, and the rapid evolution of DENV strains in many regions of the world.

Peptimmune has developed a novel peptide copolymer-based technology, DEEP (Directed Expansion of Epitope Permutations), which may overcome these problems. The goal of this research and development collaboration is to evaluate the DEEP technology to potentially design DENV-specific peptide copolymers containing (1) potentially protective T-cell epitopes, (2) serotype-specific diagnostic epitopes, and (3) protective B-cell epitopes for generating immuno-prophylactic antibodies. WRAIR/NMRC investigators bring to the effort their expert knowledge of DENV. Evaluation of the diagnostics and vaccines generated in the collaboration will be performed in laboratory models at WRAIR/NMRC.

The results of this collaborative effort have the potential to provide important insights into dengue immunity and advance the development of a protective vaccine.

About DEEP

DEEP is a pe
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
2. Peptimmune Presentations at Upcoming Events
3. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
4. Peptimmune Announces First Close of Series D Private Financing
5. Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
6. Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer, High-Quality Care to the Community
7. Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics-Based Computer Modeling of Skin Biology
8. SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
9. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
10. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
11. DuPont and Arzeda Collaborate to Develop Improved Crops to Increase Productivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Dec. 17 Reportlinker.com announces that ... in its catalogue: ,, Infectious ... http://www.reportlinker.com/p0170008/Infectious-Disease-Molecular-Diagnostic-Testing.html ,, ... clinical significance and market needs for major ... of companies developing and marketing molecular diagnostic ...
(Date:12/17/2009)... Osteotech, Inc. (Nasdaq: OSTE ), ... products for regenerative healing, announced today that it ... States Food and Drug Administration (FDA) to obtain ... BioRegeneration Matrix to repair or replace the dura ... various cranial surgical procedures. This filing is ...
(Date:12/17/2009)... BEIJING, Dec. 17 /PRNewswire-Asia/ -- Using a novel ... Chinese research/medical,team may eliminate a glioma -- brain ... in a hospital in Beijing. The treatment shows ... stem cells as well as cancer daughter,cells. The ... Comprehensive,Cancer Therapy tells Cellonis that the future vaccination ...
(Date:12/17/2009)... November, even as the overall unemployment rate edged down slightly. Additionally, ... , ... (Vocus) December 17, 2009 -- November was ... which is to say, there were no major unexpected layoffs announced ... the Pfizer acquisition of Wyeth. Meanwhile, healthcare employment continued rising in ...
Breaking Biology Technology:Reportlinker Adds Infectious Disease Molecular Diagnostic Testing 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 2For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 3For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 4The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 2The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 3
... New appointment brings in key leadership expertise to strengthen ... SIRO ClinPharm Pvt. Ltd., a ... announced the appointment of Scott L. Spector as President ... the Offenbach, Germany office of Omega Mediation . ...
... Offering the Enfant(TM) Pediatric VEP Vision Testing System, Providing ... 26 If your child had vision problems, you,d ... says Barry Goldman, M.D., pediatrician at Children,s Health Center ... with vision deficits, even those they,ve had since birth," ...
... 26 CEL-SCI Corporation (NYSE AMEX: ... an immune-based treatment for the "swine flu and related ... Antigen Presentation System) vaccine technology. The Company plans ... from developing protective and therapeutic vaccines utilizing L.E.A.P.S. to ...
Other Biology Technology:SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business 2Chicago-Area Pediatricians Offering Unique Test to Detect Vision Problems in Children as Young as Six Months of Age 2CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology 2CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology 3CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology 4
(Date:12/16/2009)... found in ocean sediment cores is illuminating the environmental ... period of Earth history. , Around 55 million years ... Earth,s poles are believed to have been free of ... years later, ice sheets covered Antarctica and continental ice ... greenhouse to icehouse conditions resulted from decreasing greenhouse gas ...
(Date:12/16/2009)... is a high priority for grape growers in the southern Napa ... be irrigated to make it through the growing season. But Stanford ... to the vines zips right by the plants, hardly even pausing. ... that is applied is lost below the vine rooting zone and ... Eve Hinckley, who worked on the project for her PhD thesis ...
(Date:12/16/2009)... more than 4 billion years before humans showed up, ... more. That suggests they may have something to teach ... expert Prof. Eshel Ben-Jacob of the Raymond and Beverly ... study of bacteria, presents compelling evidence to suggest there ... automatically opt for the swine flu H1N1 shot. , ...
Breaking Biology News(10 mins):From greenhouse to icehouse -- reconstructing the environment of the Voring Plateau 2Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3HFA Voices Blood Safety Concerns 63252 1HFA Voices Blood Safety Concerns 63252 2Fujirebio Diagnostics Named Life Sciences Company of the Year 6976 1Fujirebio Diagnostics Named Life Sciences Company of the Year 6976 2Statement From the Consumer Healthcare Products Association 28CHPA 29 on Annual Monitoring the Future Survey on Drug Abuse 6972 1Statement From the Consumer Healthcare Products Association 28CHPA 29 on Annual Monitoring the Future Survey on Drug Abuse 6972 2Statement From the Consumer Healthcare Products Association 28CHPA 29 on Annual Monitoring the Future Survey on Drug Abuse 6972 3
... POSEN, Ill., Sept. 5 Corporate Safe ... organization. The Company has hired,Thomas P. Hartmann ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080905/AQF028 ), (Logo: ... CEO of the Company, stated, "We know ...
... AMES, Iowa The National Science Foundation has ... a five-year, $18.5 million grant to establish the ... at Iowa State. , The award is part ... Research Centers (ERC) Program. The third-generation Engineering Research ...
... Populations of wild animals face the challenge of surviving ... and Universit Claude Bernard Lyon have shown how a ... coast of Scotland responds to two consequences of climate ... storms. Dr. Thomas Ezard, lead author of the study, ...
Other Biology News:Corporate Safe Specialists Launches International Sales Efforts 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 3Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 4
Request Info...
Prepared in distilled water....
... Avidin is chromatographically purified from egg white. ... is 15.5.The product is in 10 mM ... bovine serum albumin, 0.05% sodium azide and 50% ... FITC. The conjugate is purified by molecular ...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
Biology Products: